SEC Form 4 · accession 0001645627-18-000076
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President
Period of report
Nov 29, 2018
Accepted (ET)
Dec 6, 2018 · 4:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 29, 2018 | P | 2,000 | $0.0298 | A | 26,254,998 | D | |
| Common Stock | Nov 29, 2018 | P | 2,000 | $0.0314 | A | 26,256,998 | D | |
| Common Stock | Nov 29, 2018 | P | 2,000 | $0.0305 | A | 26,258,998 | D | |
| Common Stock | Nov 30, 2018 | P | 2,000 | $0.0269 | A | 26,260,998 | D | |
| Common Stock | Nov 30, 2018 | P | 2,000 | $0.0269 | A | 26,262,998 | D | |
| Common Stock | Nov 30, 2018 | P | 100 | $0.027 | A | 26,263,098 | D | |
| Common Stock | Nov 30, 2018 | P | 1,000 | $0.0269 | A | 26,264,098 | D | |
| Common Stock | Nov 30, 2018 | P | 1,000 | $0.0268 | A | 26,265,098 | D | |
| Common Stock | Nov 30, 2018 | P | 2,000 | $0.0274 | A | 26,267,098 | D | |
| Common Stock | Nov 30, 2018 | P | 2,000 | $0.0265 | A | 26,269,098 | D | |
| Common Stock | Nov 30, 2018 | P | 1,000 | $0.0275 | A | 26,270,098 | D | |
| Common Stock | Nov 30, 2018 | P | 1,000 | $0.0273 | A | 26,271,098 | D | |
| Common Stock | Nov 30, 2018 | P | 1,000 | $0.0285 | A | 26,272,098 | D | |
| Common Stock | Dec 3, 2018 | P | 1,000 | $0.0289 | A | 26,273,098 | D | |
| Common Stock | Dec 3, 2018 | P | 2,000 | $0.027 | A | 26,275,098 | D | |
| Common Stock | Dec 3, 2018 | P | 2,000 | $0.0274 | A | 26,277,098 | D | |
| Common Stock | Dec 3, 2018 | P | 2,000 | $0.0286 | A | 26,279,098 | D | |
| Common Stock | Dec 3, 2018 | P | 2,000 | $0.0289 | A | 26,281,098 | D | |
| Common Stock | Dec 3, 2018 | P | 2,000 | $0.0287 | A | 26,283,098 | D | |
| Common Stock | Dec 3, 2018 | P | 2,000 | $0.0287 | A | 26,285,098 | D | |
| Common Stock | Dec 3, 2018 | P | 2,000 | $0.0289 | A | 26,287,098 | D |
Table II — derivative securities
No Table II lines on this filing.